4th Quarter - Report
INFUSION PROVIDERS ALLIANCE for INFUSION PROVIDERS ALLIANCE
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to virtual supervision of infusion drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELLIOTT WARREN New | — |
Health Issues HCR
Advocating for access to and reimbursement for biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELLIOTT WARREN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.